ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 538,29
0,00%
Dow Jones
39 331,85
0,41%
DAX
18 164,06
-0,86%
Brent Oil
86,50
0,06%
Bitcoin
60 998,74
-1,65%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Morphic Holding Inc (MORF)

  7. Morphic Holding Inc (MORF) Actualités

MORF

Morphic (MORF)

Morphic Holding Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MORF
DateHeureSourceTitreSymboleSociété
06/06/202401h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MORFMorphic Holding Inc
05/06/202422h41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MORFMorphic Holding Inc
31/05/202414h00GlobeNewswire Inc.Morphic to Participate in Jefferies Global Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
21/05/202414h00GlobeNewswire Inc.Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking CellsNASDAQ:MORFMorphic Holding Inc
09/05/202422h05GlobeNewswire Inc.Morphic to Participate in RBC Capital Markets Global Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
25/04/202413h00GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024NASDAQ:MORFMorphic Holding Inc
19/03/202413h00GlobeNewswire Inc.Morphic Appoints Dr. Simon Cooper as Chief Medical OfficerNASDAQ:MORFMorphic Holding Inc
05/03/202422h05GlobeNewswire Inc.Morphic to Participate in March Investor ConferencesNASDAQ:MORFMorphic Holding Inc
22/02/202413h46Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MORFMorphic Holding Inc
22/02/202413h07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MORFMorphic Holding Inc
22/02/202413h00GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023NASDAQ:MORFMorphic Holding Inc
03/01/202422h05GlobeNewswire Inc.Morphic to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
10/11/202314h00GlobeNewswire Inc.Morphic to Present at November Investor ConferencesNASDAQ:MORFMorphic Holding Inc
03/11/202312h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MORFMorphic Holding Inc
03/11/202312h00GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023NASDAQ:MORFMorphic Holding Inc
09/10/202314h00GlobeNewswire Inc.Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data SetNASDAQ:MORFMorphic Holding Inc
26/09/202322h10GlobeNewswire Inc.Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of AbsenceNASDAQ:MORFMorphic Holding Inc
22/09/202323h30GlobeNewswire Inc.Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023NASDAQ:MORFMorphic Holding Inc
07/09/202322h24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MORFMorphic Holding Inc
29/08/202314h00GlobeNewswire Inc.Morphic Announces Participation in 2023 Wells Fargo Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
09/08/202322h05GlobeNewswire Inc.Morphic to Present at the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:MORFMorphic Holding Inc
03/08/202313h05GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023NASDAQ:MORFMorphic Holding Inc
24/06/202301h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MORFMorphic Holding Inc
06/06/202322h05GlobeNewswire Inc.Morphic to Present at the Jefferies Global Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
02/06/202322h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MORFMorphic Holding Inc
12/05/202314h30GlobeNewswire Inc.Morphic to Present at 2023 RBC Capital Markets Global Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
11/05/202314h00GlobeNewswire Inc.Morphic Presents New Biomarker Data at DDW 2023 Supporting MORF-057 Program in Ulcerative ColitisNASDAQ:MORFMorphic Holding Inc
05/05/202316h30GlobeNewswire Inc.Morphic Therapeutic Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:MORFMorphic Holding Inc
04/05/202312h05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MORFMorphic Holding Inc
03/05/202306h13GlobeNewswire Inc.Morphic Therapeutic Announces Pricing of $240.0 Million Public OfferingNASDAQ:MORFMorphic Holding Inc
 Showing the most relevant articles for your search:NASDAQ:MORF

Dernières Valeurs Consultées

FTSE
UKX
FTSE 100
NYSE
MRK
Merck
EU
ACA
Credit Agricole
NYSE
JPM
JP Morgan Chase
EU
BNP
BNP Paribas
NYSE
NKE
Nike
NYSE
MCD
McDonalds
EU
PX1
CAC 40
COIN
BTCUSD
Bitcoin
EU
CAP
Capgemini
NASDAQ
NVDA
NVIDIA
EU
VK
Vallourec
EU
LR
Legrand
EU
CS
Axa
EU
BEL20
Bel 20
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés